Seriously, have you consulted your doctor about any number of good antidepressants on the market ?
Airborne didn't sell a lie. They packaged and marketed well known home treatments for boosting the immune system. They saw a demand, put a product together, and pounced. Same for the others I mentioned. Cobalis is trying to do the same with Prehistin.
The main argument, if that's what it must be, is that we all (those of us who own stock) saw that potential market and agreed that this product could sell. So we bought in. We didn't care and still don't care about whether it is a "drug" that "failed" a clinical trial. Would we like it have gotten approval to be marketed that way ? Of course. But that particular clinical trial was simply a means to get the product to market. That ship sailed years ago and the plan of attack has changed drastically since then. Yet you keep bringing it up as though it is relevant today. Cobalis can and will market this vitamin remedy for allergy prevention with full FDA approval to do so as long as the marketing and packaging include the proper labeling.
And since we are splitting hairs, clinical trials are not "tests" and they are not conducted by the the FDA. They are statistical experiments conducted by the patent owner. They often fail to produce the expected results for a number of reasons. If you have taken a statistics survey course in your life, or at least read a book on the subject, you understand that a statistical experiment can only show statistical significance that indicate and effect is real. It cannot disprove an effect, and therefore cannot prove that the product does NOT work, as you suggest. I am splitting hairs because IMO you are either ignorant of what you speak, or you are intentionally using kurt, negative language to misguide others who are equally ignorant to the topic. I am trying to educate other stock holders and potential stock holders on how the FDA works, since I have been in the pharmaceutical and biotech industries (yes, they are two different things) for many years and have helped several companies acquire FDA approval. I have also helped them maintain GMP compliance per FDA CFR 21 Parts 210 and 211 for their manufacturing facilities.
I didn't mean to say or indicate that the ONLY problem is the accounting and trading. However, I do believe strongly, that if this stock we in full trading mode, even on the pinks, the price would have gone up significantly once the first box hit a real shelf at CVS and shorters (such as yourself?) would be hurting really badly. And "significantly" does not mean dollars or anything crazy. I simply mean statistically significant amount exceeding its own and market trends over a short to medium time period.
Finally, I do appreciate you best wishes, but I do not need a miracle nor do I need luck. I am in this stock for fun, quite frankly. My real money comes from other pharma stocks that I understand much better, such as WPI that I bought for around $21 in late 2008 that is now trading at around $63.Sure I'll take a miracle and would like to see CLSC at either of those two prices. But I'm one of the few who really doesn't care, I just don't like to see people get so spun up over what is essentially the lowest probability gamble they could have made other than playing Vegas slots - buying penny stocks.
AI
